- Record: found
- Abstract: not found
- Article: not found
Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha: Low levels of residual disease are associated with continuous remission
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.